Expression of total and phospho 4EBP1 in metastatic and non‑metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Expression of total and phospho 4EBP1 in metastatic and non‑metastatic renal cell carcinoma

Published:2019-02-12 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Naito Sei¹,Ichiyanagi Osamu¹,Ito Hiromi¹,Kabasawa Takanobu²,Kanno Hidenori¹,Narisawa Takafumi¹,Fukuhara Hiroki¹,Yagi Mayu¹,Kurota Yuta¹,Yamagishi Atsushi¹,Sakurai Toshihiko¹,Nishida Hayato¹,Kawazoe Hisashi¹,Yamanobe Takuya¹,Kato Tomoyuki¹,Makhov Peter³,Kolenko Vladimir³,Yamakawa Mitsunori²,Tsuchiya Norihiko¹

Affiliation:

1. Department of Urology, Yamagata University Faculty of Medicine, Yamagata, Yamagata 990‑9585, Japan

2. Department of Pathological diagnostics, Yamagata University Faculty of Medicine, Yamagata, Yamagata 990‑9585, Japan

3. Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Necrosis Factor Receptor-2 Signals Clear-Cell Renal Carcinoma Proliferation via Phosphorylated 4E Binding Protein-1 and Mitochondrial Gene Translation;The American Journal of Pathology;2024-07

2. High EIF4EBP1 expression reflects mTOR pathway activity and cancer cell proliferation and is a biomarker for poor breast cancer prognosis;American Journal of Cancer Research;2024

3. Potential Therapeutic Strategies to Combat HCC;Current Molecular Pharmacology;2022-12

4. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts;Scientific Reports;2022-11-11